Prevention of NAFLD-associated HCC: Role of lifestyle and chemoprevention

被引：94
|
作者：
Lange, Naomi F. [1 ,2 ]
Radu, Pompilia [1 ]
Dufour, Jean-Francois [1 ]
机构：
[1] Inselspital Bern, Univ Clin Visceral Surg & Med, Bern, Switzerland
[2] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland
来源：
JOURNAL OF HEPATOLOGY | 2021年 / 75卷 / 05期
关键词：
Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Hepatocellular carcinoma; Prevention; Lifestyle; Diet; Physical activity; Coffee; Alcohol; Aspirin; Statins; Probiotics; FATTY LIVER-DISEASE; RANDOMIZED CONTROLLED-TRIAL; HEPATOCELLULAR-CARCINOMA; HEPATITIS-C; VIRAL-HEPATITIS; RISK-FACTORS; WEIGHT-LOSS; MEDITERRANEAN DIET; DIABETIC-PATIENTS; ALCOHOL-DRINKING;
D O I：
10.1016/j.jhep.2021.07.025
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
In many countries worldwide, the burden of hepatocellular carcinoma (HCC) associated with nonalcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) is increasing. Preventive strategies are needed to counteract this trend. In this review, we provide an overview of the evidence on preventive strategies in NAFLD-associated HCC. We consider the impact of lifestyle factors such as weight loss, physical activity, smoking, dietary patterns and food items, including coffee and alcohol, on both HCC and NAFLD/NASH. Furthermore, evidence on chemopreventive treatments, including aspirin, antidiabetic treatments and statins is summarised. The role of adjuvant therapies for tertiary prevention of HCC is briefly reviewed. (C) 2021 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.
引用
收藏
页码：1217 / 1227
页数：11
相关论文
共 50 条
  • [41] TREM2 modulates metabolic crosstalk between macrophage and hepatocyte in NAFLD-associated sepsis
    Zhang, Jue
    Fang, Xiangming
    ANESTHESIA AND ANALGESIA, 2021, 133 (3S_SUPPL): : 924 - 924
  • [42] SPARC inhibition accelerates NAFLD-associated hepatocellular carcinoma development by dysregulating hepatic lipid metabolism
    M. Onorato, Agostina
    Fiore, Esteban
    Bayo, Juan
    Casali, Cecilia
    Fernandez-Tome, Maria
    Rodriguez, Marcelo
    Dominguez, Luciana
    Argemi, Josepmaria
    Hidalgo, Florencia
    Favre, Cristian
    Garcia, Mariana
    Atorrasagasti, Catalina
    Mazzolini, Guillermo D.
    LIVER INTERNATIONAL, 2021, 41 (07) : 1677 - 1693
  • [43] PREVALENCE OF NAFLD-ASSOCIATED GENE VARIANTS AMONG WOMEN WITH PREECLAMPSIA AND GESTATIONAL DIABETES DURING PREGNANCY
    Carroll, Carin
    Sigel, Keith
    Abul-Husn, Noura S.
    Kushner, Tatyana
    GASTROENTEROLOGY, 2022, 162 (07) : S1208 - S1208
  • [44] Cancer prevention in hereditary colorectal cancer syndromes: Chemoprevention and lifestyle changes
    Baucom, Rebeccah
    Wells, Katerina
    SEMINARS IN COLON AND RECTAL SURGERY, 2018, 29 (03) : 128 - 132
  • [45] Role of antiviral treatment for HCC prevention
    Colombo, Massimo
    Iavarone, Massimo
    BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2014, 28 (05) : 771 - 781
  • [46] DISCOVERY OF NAFLD-ASSOCIATED SOMATIC VARIANT FEATURES THROUGH OPTIMIZED CALLING PIPELINE FOR WHOLE GENOME SEQUENCING
    Jung, Sungju
    Yoon, Sumin
    Han, Suhyang
    Jang, Sunyoung
    Oh, Chaeun
    Ryu, Kyung Hyun
    Park, Jong Hoon
    HEPATOLOGY, 2023, 77 (05) : E166 - E166
  • [47] Histone deacetylase 8 impairs insulin sensitivity and activates β-catenin signaling in NAFLD-associated hepatocellular carcinoma
    Tian, Yuan
    To, Ka F.
    Lai, Paul B. S.
    Cheung, Yue S.
    Yu, Jun
    Wong, Vincent W. S.
    Chan, Henry L. Y.
    Cheng, Alfred S. L.
    CANCER RESEARCH, 2015, 75
  • [48] FROM NAFLD TO HCC: THE ROLE OF FIBROSIS AS A COFACTOR IN A NEW MOUSE MODEL
    De Minicis, S.
    Rychlicki, C.
    Trozzi, L.
    Agostinelli, L.
    Candelaresi, C.
    Marzioni, M.
    Benedetti, A.
    Svegliati-Baroni, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S12 - S12
  • [49] FROM NAFLD TO HCC: THE ROLE OF FIBROSIS AS A COFACTOR IN A NEW MOUSE MODEL
    De Minicis, S.
    Rychlicki, C.
    Trozzi, L.
    Agostinelli, L.
    Candelaresi, C.
    Orlando, F.
    Provinciali, M.
    Marzioni, M.
    Benedetti, A.
    Svegliati-Baroni, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S151 - S152
  • [50] FROM NAFLD TO HCC: THE ROLE OF FIBROSIS AS A COFACTOR IN A NEW MOUSE MODEL
    De Minicis, Samuele
    Rychlicki, Chiara
    Trozzi, Luciano
    Agostinelli, Laura
    Saccomanno, Stefania
    Candelaresi, Cinzia
    Marzioni, Marco
    Benedetti, Antonio
    Svegliati-Baroni, Gianluca
    HEPATOLOGY, 2010, 52 (04) : 943A - 943A
12345